5:43 AM
 | 
Jan 03, 2019
 |  BC Innovations  |  Distillery Therapeutics

Pulmonary

INDICATION: Pulmonary fibrosis

Patient sample and mouse studies suggest inhibiting MUC5B polymerization could help treat pulmonary fibrosis. In lung samples from IPF patients, epithelial cell levels of MUC5B, which forms polymeric gels...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >